TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rhythm Biosciences Ltd. ( (AU:RHY) ) has issued an announcement.
Rhythm Biosciences Limited has released a report detailing the holdings of its listed options, which are set to expire on November 30, 2027. The report indicates that a significant portion of the options, 96.67%, is held by a small group of 67 holders, with the top holder being HSBC Custody Nominees (Australia) Limited, owning 10.06% of the issued share capital. This concentration of holdings could have implications for the company’s market dynamics and investor relations, as it suggests a limited distribution of shares among a few stakeholders.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Average Trading Volume: 348,097
Technical Sentiment Signal: Buy
Current Market Cap: A$28.34M
Find detailed analytics on RHY stock on TipRanks’ Stock Analysis page.